Dark pool activity was detected in HCA stock on January 29, 2020.
The dark pool order occurred in pre-market trading which is bit unusual. We are unable to determine if the dark pool trade was a buy or sell order.
SunTrust analyst David MacDonald raised his price target on HCA Healthcare to $185 and kept his Buy rating after its Q4 results. MacDonald says that HCA has significant running room for capital investment. He also says that the quarter was driven by strong same-facility volumes, market share gains, and robust cash flows. David thinks that the company is well positioned given its premium assets in growing markets and a sizable outpatient presence.
Oppenheimer analyst Michael Wiederhorn raised his price target for HCA Healthcare to $160 from $155, citing a strong Q4 and solid 2020 guidance. He has an Outperform rating on the shares.
On January 28, 2020, HCA Healthcare, Inc. (NYSE: HCA) announced financial and operating results for the fourth quarter ended December 31, 2019. HCA Healthcare reported Q4 EPS of $3.09 which was in-line with estimates. The company reported Q4 revenue of $13.52B versus the consensus estimate of $13.37B.
Revenues in the fourth quarter of 2019 increased to $13.523 billion, compared to $12.274 billion in the fourth quarter of 2018. Net income attributable to HCA Healthcare, Inc. totaled $1.071 billion, or $3.09 per diluted share, compared to $1.064 billion, or $3.01 per diluted share, in the fourth quarter of 2018. Results for the fourth quarter of 2018 included gains on sales of facilities of $8 million, or $0.02 per diluted share. In the fourth quarter of 2018 we recorded a $67 million, or $0.19 per diluted share, favorable adjustment to our deferred tax assets and liabilities related to the impact of the Tax Cuts and Jobs Act.
For the fourth quarter of 2019, Adjusted EBITDA totaled $2.738 billion, compared to $2.508 billion in the fourth quarter of 2018. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.
During the fourth quarter of 2018, the Company incurred additional expenses and experienced losses of revenues estimated at $31 million, or $0.07 per diluted share, associated with Hurricane Michael’s impact on our Florida panhandle facilities. This amount is prior to any potential insurance recoveries. Also, during the fourth quarter of 2018, the Company recorded a benefit of $49 million, or $0.11 per diluted share, from an insurance recovery related to Hurricane Harvey business interruption losses incurred during 2017.
Same facility admissions and same facility equivalent admissions increased 4.7 percent and 5.0 percent, respectively, in the fourth quarter of 2019 compared to the prior year period. Same facility emergency room visits increased 6.7 percent in the fourth quarter of 2019, compared to the prior year period. Same facility inpatient surgeries increased 2.1 percent, and same facility outpatient surgeries increased 1.8 percent in the fourth quarter of 2019, compared to the same period of 2018. Same facility revenue per equivalent admission increased 1.1 percent in the fourth quarter of 2019, compared to the fourth quarter of 2018.
The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $2 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management’s discretion from time to time in the open market, through privately negotiated transactions, or otherwise. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.